Back to News
Market Impact: 0.42

Forgent Stock Up 30% Since Strong Q4: Buy for More Upside?

Source: zacks.com

Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsArtificial IntelligenceInfrastructure & DefenseAnalyst Insights
Forgent Stock Up 30% Since Strong Q4: Buy for More Upside?

Forgent Power Solutions’ fiscal 2026 backlog reached a record $3 billion, up 256% year over year and covering more than 90% of fiscal 2027 revenue guidance of $2.4-$2.6 billion. Management forecasts fiscal 2027 adjusted EPS of $1.26-$1.40, up 95% at the midpoint, and adjusted EBITDA of $575-$625 million; fiscal 2026 data-center revenue grew 161%. Shares had risen 29.5% since results but fell 7% after JPMorgan trimmed its price target while maintaining an Overweight rating; the article cites average analyst targets implying roughly 45%-50% upside, while noting execution risks in converting backlog to revenue.

Analysis

The key question is not whether demand exists; it is whether Forgent can turn an unusually concentrated order book into shipped systems and cash without sacrificing margins. Backlog coverage reduces near-term demand uncertainty, but does not eliminate cancellation, timing, customer-concentration, or production-ramp risk. Verify order terms, customer concentration, shipment timing, and working-capital needs before treating backlog as near-certain earnings.

Over the next 1–3 months, the stock is vulnerable to a “show me” reset: after a sharp rerating, any shortfall in shipments, margin conversion, or cash generation could overwhelm favorable demand commentary. The announced Tijuana capacity is a 6–18 month execution catalyst, not evidence of near-term sellable output. Power availability, permitting, and data-center project delays could also defer customer schedules and leave new capacity underutilized.

The bullish case is differentiated share capture, not simply AI exposure. If integrated powertrain systems and short lead times are winning business, Forgent may take share from larger electrical-equipment suppliers; however, one year of outgrowth does not establish durable pricing power. ETN and NVT offer broader exposure and potentially less single-company ramp risk. The article’s peer-multiple comparison is not decisive: FPS’s apparent discount only matters if forecast EPS is delivered, while rapid forecast growth can make a forward P/E look deceptively inexpensive.

Contrarian view: enthusiasm may be underpricing execution risk, even if the longer-term demand thesis is sound. Treat bullish sell-side targets as assumptions, not catalysts; the reported target upside is not independently validated here.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.62

Ticker Sentiment

ETN0.10
FPS0.85
JPM-0.15
NVT0.10

Key Decisions for Investors

  • Consider a staged, modest long in FPS rather than chasing a full position after the rally. Add only as reported shipments, adjusted EBITDA, and operating cash flow confirm the FY2027 outlook; avoid using backlog growth alone as the add signal.
  • For a relative-value expression of share-gain potential, evaluate long FPS versus short NVT, but size conservatively and confirm current valuation, borrow availability, and liquidity first. The pair is exposed to FPS execution and could lose if demand broadens across suppliers without FPS converting orders faster.
  • Use the next earnings update as the principal 1–3 month catalyst. Verify backlog conversion and cancellation terms, customer concentration, segment margins, working-capital absorption, and whether the new facility remains on schedule.
  • Falsify the long thesis if management cuts FY2027 revenue or EBITDA guidance, shipment delays prevent backlog conversion, cash generation materially misses its stated trajectory, or margins deteriorate as volume scales. A broad slowdown or deferral in hyperscaler data-center spending would weaken the sector thesis as well.

More News

From AllMind Research

Browse all research